Press Releases Genscript Biotech Corporation

Stocks

1548

KYG3825B1059

Biotechnology & Medical Research

Market Closed - Hong Kong S.E. Other stock markets 09:08:36 10/07/2026 BST			5-day change	1st Jan Change
13.84 ^HKD	+4.85%		+1.69%	+11.43%

06-15	Genscript Associate Reports Promising Phase 1 Data for LB2501 in B-Cell Lymphoma	MT
06-14	Genscript Biotech Corporation Reports 100% Response Rate in Early Trial of LB2501 Dual-Targeting CAR-T Therapy for Relapsed B-Cell Lymphoma	CI

Press Releases

03-16	GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth	PR
12/03/25	GenScript Biotech Corporation Reports FY 2024 Results	PR
15/01/25	GenScript upgrades product packaging with a recyclable strategy, reducing waste by 82% and contributing to environmental sustainability	AQ
21/11/24	The GenScript Biotech Global Forum Makes a Strong Debut in Europe, Highlighting Breakthroughs in Cell and Gene Therapy Development	PR
15/11/24	GenScript Subsidiary ProBio Instrumental in Latest Fight Against Cancer	PR
14/10/24	GenScript Biotech Advances Sustainable Development with MSCI ESG Rating Upgrade to A	AQ
12/09/24	GenScript Appoints New Board Members to Drive Global Growth	PR
28/08/24	GenScript Subsidiary Legend Biotech Achieves Breakthrough with Cilta-cel Approval in China, Offering New Hope for Multiple Myeloma Patients	AQ
25/04/24	GenScript Biotech Releases 2023 ESG Report, Deepening Green Development Practices, Constructing Sustainable Future Blueprint	AQ
25/04/24	Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing	BU
24/04/24	GenScript Biotech Releases 2023 ESG Report: Deepening Green Development Practices, Constructing Sustainable Future Blueprint	PR
24/04/24	Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing	AQ
16/04/24	GenScript Biotech officially joins SBTi to fulfill its sustainability commitment	AQ
27/03/24	GenScript Biotech Receives EcoVadis Bronze Medal for Outstanding Sustainability Performance	AQ
06/03/24	Immunotherapy Pioneer Carl H. June, MD, Joins GenScript's Scientific Advisory Board to Guide Company's Innovation Strategy in Advancing Cell and Gene Therapy Breakthroughs	PR
05/02/24	GenScript Announces Its Inaugural Life Science Research Grant Project	PR
12/01/24	San Francisco Witnesses the Voice of GCT Titans GenScript Biotech Global Forum Outlines the Future of the Industry	PR
04/01/24	GenScript, GenScript ProBio, and Legend Biotech Will Attend the 42nd JPM Healthcare Conference, Advancing Innovation and Development in the Healthcare Sector	PR
04/01/24	GenScript Biotech Global Forum 2024 to Commence, Infusing New Vitality into the GCT Industry	PR
25/12/23	FDA Keynote Speaker in the Spotlight, CAR-T Industry Leaders Gather for Discussion-Join the 2024 GenScript Biotech Global Forum for a New Journey in Cell and Gene Therapy	PR
14/12/23	GenScript to Host Biotech Global Forum 2024 during 42nd Annual J.P. Morgan Healthcare Conference	PR
07/12/23	CRISPR Continuous to Innovate! Exploring the Future of Cell & Gene Therapy, Industry Leaders Converge at the 2024 GenScript Biotech Global Forum	PR
04/12/23	GenScript Named a BioSpace 2024 Best Place to Work	AQ
01/12/23	GenScript Named a BioSpace 2024 Best Place to Work	PR
10/11/23	GenScript ProBio Partners with Epi Biotech to Advance Hair Loss Antibody Therapy	AQ